Indian manufacturers urge for stricter scrutiny, citing data privacy, quality, and national security concerns

India’s domestic medical technology (MedTech) manufacturers have raised serious alarms regarding the increasing penetration of Chinese medical devices in the Indian healthcare ecosystem, flagging major concerns about national security, data privacy, and patient safety. The concerns have gained traction amid rising geopolitical tensions and a growing push for Atmanirbhar Bharat (self-reliant India) in critical sectors like healthcare and technology.

Concerns Over Data Integrity and Surveillance Risks

Industry experts and domestic manufacturers argue that Chinese-origin medical devices especially in high-risk categories like diagnostic imaging systems, patient monitors, and implantable devices pose potential cybersecurity threats. Many of these devices are embedded with chips and software capable of collecting, storing, and transmitting sensitive patient data. Without proper regulatory oversight or transparency, this data could be accessed remotely, raising surveillance and privacy concerns.

A senior executive from a leading Indian MedTech firm stated, “There is growing unease that certain imported devices could be used as digital backdoors into hospital IT systems, risking patient confidentiality and institutional data integrity. Unlike Indian manufacturers, many of these overseas players are not transparent about software codes or firmware updates.”

Call for Regulatory Intervention and Indigenous Promotion

Domestic manufacturers have urged the central government and regulatory bodies, such as the Central Drugs Standard Control Organisation (CDSCO), to implement stringent certification, quality audits, and security compliance for all imported medical devices—particularly those from China.

The Association of Indian Medical Device Industry (AiMeD), representing over 400 domestic companies, has called for an urgent review of procurement practices in both public and private hospitals. The association is pushing for:

Mandatory security vetting of imported MedTech devices

Preferential procurement policies for indigenous manufacturers

Encouraging R&D and manufacturing under the Production Linked Incentive (PLI) scheme

Clear labeling and traceability of country of origin for all medical equipment

Rajiv Nath, Forum Coordinator of AiMeD, emphasized, “It’s not just about economics anymore—it’s a question of sovereignty, trust, and resilience. We cannot afford to become dependent on systems that may have hidden vulnerabilities.”

Government Response and Ongoing Discussions

The government has acknowledged industry concerns and is reportedly considering a policy framework to address cybersecurity risks associated with foreign-manufactured medical devices. Discussions are underway to include cybersecurity certifications in the Quality Management System (QMS) for medical devices, as well as to enhance the ‘Make in India’ footprint in this critical sector.

Meanwhile, leading hospitals and healthcare institutions have begun internal reviews of their procurement pipelines, ensuring that devices with potential software-based vulnerabilities are either sandboxed or replaced with domestically produced alternatives wherever feasible.

A Strategic Imperative for National Health Security

In light of increasing digitization of healthcare and the integration of AI, IoT, and cloud-based platforms into critical medical infrastructure, ensuring data sovereignty and system integrity has become a strategic imperative. India’s domestic MedTech industry is urging for a collaborative ecosystem where innovation, security, and self-reliance go hand in hand.

The coming months are expected to witness greater regulatory action, industry-government collaboration, and public discourse on how India can build a secure and globally competitive MedTech ecosystem rooted in safety, transparency, and trust.